Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia Chronic Lymphocytic Leukemia (CLL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05590702
What this trial is testing

French Observational Study of Patients With Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma in Real-World Settings

Who this might be right for
CLL/SLL
French Innovative Leukemia Organisation 1,000
Testing effectiveness (Phase 2)Study completedNCT00286780
What this trial is testing

Phase 2 Safety and Efficacy Study of AT-101 in Combination With Rituximab in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Ascenta Therapeutics 19
Testing effectiveness (Phase 2)Study completedNCT00571662
What this trial is testing

Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+6 more
University of Nebraska 76
Early research (Phase 1)Ended earlyNCT02784834
What this trial is testing

Dimethylfumarate (DMF) in Relapsed/Refractory CLL/SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Michael Choi 2
Testing effectiveness (Phase 2)Ended earlyNCT00899353
What this trial is testing

Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple MyelomaChronic Lymphocytic Leukemia
Marshall University 16
Testing effectiveness (Phase 2)Study completedNCT01520519
What this trial is testing

Phase 2 Study of the Combination of Bruton's Tyrosine Kinase Inhibitor PCI-32765 and Rituximab in High-Risk Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Patients

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00248430
What this trial is testing

Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+1 more
Fred Hutchinson Cancer Center 20
Early research (Phase 1)Active Not RecruitingNCT05618028
What this trial is testing

Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets

Who this might be right for
Diffuse Large B-Cell LymphomaChronic Lymphocytic LeukemiaB Cell Malignancies+1 more
AbbVie 78
Testing effectiveness (Phase 2)Active Not RecruitingNCT03580928
What this trial is testing

Acalabrutinib, Venetoclax, and Obinutuzumab for Initial Therapy of CLL

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
Dana-Farber Cancer Institute 72
Early research (Phase 1)Ended earlyNCT02848911
What this trial is testing

Safety Study to Assess AFM11 in Patients With Relapsed or Refractory Adult B-precursor ALL

Who this might be right for
Leukemia, B-Cell
Affimed GmbH 17
Large-scale testing (Phase 3)Active Not RecruitingNCT03836261
What this trial is testing

Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL

Who this might be right for
Chronic Lymphocytic Leukemia
Acerta Pharma BV 984
Early research (Phase 1)Study completedNCT02669017
What this trial is testing

Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)

Who this might be right for
Non-Hodgkin LymphomaBurkitt's LymphomaChronic Lymphocytic Leukemia+6 more
ADC Therapeutics S.A. 183
Testing effectiveness (Phase 2)Study completedNCT00006390
What this trial is testing

Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)WithdrawnNCT00504491
What this trial is testing

R-CHOP and Alemtuzumab in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukaemiaPatients Resistant to a Purine AnalogousPatients Relapsed With Purines Therapy
CABYC
Early research (Phase 1)UnknownNCT00090727
What this trial is testing

Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Solid MalignanciesNon-Hodgkin's Lymphoma
Novacea 45
Testing effectiveness (Phase 2)Study completedNCT03455517
What this trial is testing

Activity and Safety of Front-line Venetoclax and Rituximab in Young and Fit Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 77
Testing effectiveness (Phase 2)Study completedNCT00003808
What this trial is testing

Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group
Not applicableUnknownNCT05619861
What this trial is testing

CAR-T Cells in the Treatment of Malignant Hematological Tumors

Who this might be right for
Lymphoma, B-CellLeukemia, B-cellLeukemia, T-Cell+1 more
Hebei Senlang Biotechnology Inc., Ltd. 20
Early research (Phase 1)Study completedNCT00303797
What this trial is testing

Sorafenib and Bortezomib in Treating Patients With Advanced Cancer

Who this might be right for
Refractory Chronic Lymphocytic LeukemiaRefractory Multiple MyelomaStage III Multiple Myeloma+2 more
National Cancer Institute (NCI) 50
Post-approval studies (Phase 4)Ended earlyNCT02608060
What this trial is testing

Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B

Who this might be right for
Anemia
Hoffmann-La Roche 4
Next Page